Eye implants may improve macular edema in diabetes

08/2/2011 | Endocrine Today

Using low- and high-dose fluocinolone acetonide implants improved the visual acuity of patients with diabetes-related macular edema, according to a FAME trial. However, researchers found that those without the implants had a lower risk of surgery for glaucoma. Surgery was required for 3.7% of patients in low-dose group and 7.6% in high-dose group.

View Full Article in:

Endocrine Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA